RBC Capital on Neurocrine Bio. (NBIX): 'We like the setup and remain buyers'

September 8, 2026 9:15 AM

RBC Capital analyst Brian Abrahams reiterated an Outperform rating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

StreetInsider